NervGen Pharma Corp. Common stock
NGEN | NASDAQ
$1.41
+$0.04 (+2.92%)
Nov 2, 2026, 11:20 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 22.07M | 17.26M | 11.66M | 22.25M | 17.06M | 5.61M |
Short-Term Investments | n/a | 97.17K | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 8.36K | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | 80.83K | 415.02K | 250.23K | 26.79K | 64.49K | 62.73K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 8.37K | 1.02M | 388.04K | 525.32K | 313.36K | 456.49K |
Total Current Assets | 22.8M | 19M | 12.52M | 22.94M | 17.55M | 6.22M |
Property-Plant & Equipment | n/a | n/a | 199.8K | 292.68K | 2.71K | 2K |
Goodwill & Intangibles | 409.16K | 464.65K | 520.8K | 427.61K | 476.75K | 472.45K |
Total Long-Term Assets | 409.16K | 473.01K | 720.59K | 720.29K | 479.46K | 474.45K |
Total Assets | 23.21M | 19.47M | 13.24M | 23.67M | 18.03M | 6.69M |
Account Payables | 4.66M | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 97.17K | 91.59K | 85.51K | n/a | n/a |
Other Current Liabilities | 15.07M | 15.63M | 14.61M | 9.54M | 1.09M | 756.78K |
Total Current Liabilities | 19.73M | 16.89M | 15.14M | 10.13M | 1.09M | 756.78K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | 8.36K | 105.61K | 195.46K | n/a | n/a |
Total Liabilities | 19.73M | 16.9M | 15.25M | 10.32M | 1.09M | 756.78K |
Total Debt | 8.37K | 105.53K | 197.21K | 280.96K | n/a | n/a |
Book Value | 3.48M | 2.57M | -2.01M | 13.34M | 16.95M | 5.93M |
Book Value Per Share | 0.05 | 0.04 | -0.03 | 0.25 | 0.43 | 0.18 |
Common Stock | 103M | 81.05M | 58.94M | 56.91M | 42.73M | 23M |
Retained Earnings | -146.76M | -102.09M | -78.16M | -55.28M | -35.32M | -22.37M |
Comprehensive Income | n/a | 23.62M | 17.21M | 11.72M | 9.54M | 5.31M |
Shareholders Equity | 3.48M | 2.57M | -2.01M | 13.34M | 16.95M | 5.93M |
Total Investments | n/a | 105.53K | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NGEN